Drug Type Monoclonal antibody |
Synonyms Anti-L-selectin monoclonal antibodies, Anti-L-selectin monoclonal antibody DREG 200, Anti-L-selectin monoclonal antibody DREG 55 + [11] |
Target |
Action inhibitors |
Mechanism L-sel inhibitors(Leukocyte adhesion molecule-1 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |


| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | Anti-L-selectin monoclonal antibodies(PDL BioPharma, Inc.) | - | - |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Shock | Phase 2 | Europe | - | - |
| Shock | Phase 2 | - | - | |
| Psoriasis | Phase 1 | Europe | - | - |
| Psoriasis | Phase 1 | - | - | |
| Crohn Disease | Preclinical | Europe | - | - |
| Crohn Disease | Preclinical | - | - | |
| Reperfusion Injury | Preclinical | United States | - | |
| Respiratory Distress Syndrome, Adult | Preclinical | United States | - | |
| Respiratory Distress Syndrome, Newborn | Preclinical | - | - |






